On Monday, Immunic Inc (NASDAQ: IMUX) was 3.13% up from the session before settling in for the closing price of $1.28. A 52-week range for IMUX has been $0.97 – $2.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 54.30%. With a float of $87.36 million, this company’s outstanding shares have now reached $90.08 million.
Let’s look at the performance matrix of the company that is accounted for 77 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Immunic Inc (IMUX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Immunic Inc stocks. The insider ownership of Immunic Inc is 3.02%, while institutional ownership is 62.53%. The most recent insider transaction that took place on Nov 12 ’24, was worth 100,369. In this transaction Director of this company bought 87,300 shares at a rate of $1.15, taking the stock ownership to the 87,300 shares.
Immunic Inc (IMUX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 54.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.50% during the next five years compared to 31.12% growth over the previous five years of trading.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
You can see what Immunic Inc (IMUX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.24, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.76 in one year’s time.
Technical Analysis of Immunic Inc (IMUX)
Immunic Inc (NASDAQ: IMUX) saw its 5-day average volume 0.82 million, a positive change from its year-to-date volume of 0.63 million. As of the previous 9 days, the stock’s Stochastic %D was 53.90%. Additionally, its Average True Range was 0.10.
During the past 100 days, Immunic Inc’s (IMUX) raw stochastic average was set at 27.52%, which indicates a significant decrease from 75.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 81.20% in the past 14 days, which was higher than the 75.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3215, while its 200-day Moving Average is $1.3343. Nevertheless, the first resistance level for the watch stands at $1.3533 in the near term. At $1.3867, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.4233. If the price goes on to break the first support level at $1.2833, it is likely to go to the next support level at $1.2467. The third support level lies at $1.2133 if the price breaches the second support level.
Immunic Inc (NASDAQ: IMUX) Key Stats
There are 90,079K outstanding shares of the company, which has a market capitalization of 118.90 million. As of now, sales total 0 K while income totals -93,610 K. Its latest quarter income was 0 K while its last quarter net income were -24,370 K.
